Urokinase receptor expression on human microvascular endothelial cells is increased by hypoxia: Implications for capillary-like tube formation in a fibrin matrix

Blood

Volumn 96, Issue 8, 2000, Pages 2775-2783

  Kroon, M E ^a   Koolwijk, P ^a   Van der Vecht, B ^a   Van Hinsbergh, V W M ^a  

^a TNO   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

FIBRIN; FIBROBLAST GROWTH FACTOR 2; INTEGRIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PLASMIN; PLASMINOGEN ACTIVATOR; TISSUE PLASMINOGEN ACTIVATOR; TUMOR NECROSIS FACTOR ALPHA; UROKINASE; UROKINASE RECEPTOR; VASCULOTROPIN;

ANGIOGENESIS; ARTICLE; CAPILLARY FLOW; CONTROLLED STUDY; GROWTH RATE; HUMAN; HUMAN CELL; HYPOXIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; VASCULAR ENDOTHELIUM;

EID: 0034667619     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v96.8.2775.h8002775_2775_2783     Document Type: Article

References (66)

1. Ischemia-driven angiogenesis
2. Growth regulation of the vascular system: Evidence for a metabolic hypothesis
3. Regulation of wound-healing angiogenesis-effect of oxygen gradients and inspired oxygen concentration
4. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
5. Oxygen tension regulates the expression of the platelet-derived growth factor-B chain gene in human endothelial cells
6. Hypoxia-mediated induction of acidic/basic fibroblast growth factor and platelet-derived growth factor in mononuclear phagocytes stimulates growth of hypoxic endothelial cells
7. Conditioned media of carcinoma cells cultured in hypoxic microenvironment stimulate angiogenesis in vitro: Relationship to basic fibroblast growth factor
8. Increased expression of placenta growth factor in proliferative diabetic retinopathy
9. Oxygen tension regulates the expression of angiogenesis factor by macrophages
10. Production of vascular endothelial growth factor by murine macrophages: Regulation by hypoxia, lactate, and the inducible nitric oxide synthase pathway
11. Regulation of macrophage production of vascular endothelial growth factor (VEGF) by hypoxia and transforming growth factor beta-1
12. Serotonin uptake by bovine pulmonary artery endothelial cells in culture, II: Stimulation by hypoxia
13. Reduced oxygen tension induces pulmonary endothelium to release a pulmonary smooth muscle cell mitogen(s)
14. Manipulating angiogenesis: From basic science to the bedside
15. Fibrin containing gels induce angiogenesis: Implications for tumor stroma generation and wound healing
16. Role of fibrin and plasminogen activators in repair-associated angiogenesis: In vitro studies with human endothelial cells
17. Transforming growth factor-b-1 modulates basic fibroblast growth factor induced proteolytic and angiogenic properties of endothelial cells in vitro
18. Cooperative effect of TNFalpha, bFGF, and VEGF on the formation of tubular structures of human microvascular endothelial cells in a fibrin matrix: Role of urokinase activity
19. Role and localization of urokinase receptor in the formation of new microvascular structures in fibrin matrices
20. Recycling of the urokinase receptor upon internalization of the uPA:Serpin complexes
21. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice
22. Inhibition of prostate cancer neovascularization and growth by urokinase-plasminogen activator receptor blockade
23. Identification of the urokinase receptor as cell adhesion receptor for vitronectin
24. Urokinase receptor is a multifunctional protein: Influence of receptor occupancy on macrophage gene expression
25. Regulation of integrin function by the urokinase receptor
26. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin
27. Urokinase receptor-dependent upregulation of smooth muscle cell adhesion to vitronectin by urokinase
28. Urokinase activates the Jak/Stat signal transduction pathway in human vascular endothelial cells
29. The urokinase-type plasminogen activator receptor mediates tyrosine phosphorylation of focal adhesion proteins and activation of mitogen-activated protein kinase in cultured endothelial cells
30. Cell type specific upregulation of vascular endothelial growth factor in an MCA-occlusion model of cerebral infarct
31. Hypoxia induces vascular endothelial growth factor in cultured human endothelial cells
32. Hypoxic stimulation of vascular endothelial growth factor expression in vitro and in vivo
33. Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors
34. Functional upregulation of the vascular endothelial growth factor receptor KDR by hypoxia
35. Hypoxia regulates the expression of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) and its receptors in human skin
36. Hypoxia and vascular endothelial growth factor stimulate angiogenic integrin expression in bovine retinal microvascular endothelial cells
37. The role of alphav integrins during angiogenesis: Insights into potential mechanisms of action and clinical development
38. Reduction in pO2 decreases the fibrinolytic potential of cultured bovine endothelial cells derived from pulmonary arteries and lung microvasculature
39. Hypoxia stimulates urokinase receptor expression through a heme protein-dependent pathway
40. An endothelial cell growth factor from bovine hypothalamus: Identification and partial characterization
41. Demonstration of urokinase-related fibrinolytic activity in human plasma
42. Urokinase plasminogen activator receptor, beta 2-integrins, and Src-kinases within a single receptor complex of human monocytes
43. Glucocorticoid-modulated gene expression of tissue- and urinary type plasminogen activator and plasminogen activator inhibitor 1 and 2
44. Cloning and expression of the receptor for human urokinase plasminogen activator: A central molecule in cell surface, plasmin dependent proteolysis
45. The genes coding for the cytoskeletal proteins actin and vimentin in warm-blooded vertebrates
46. Effect of thrombin on the production of plasminogen activators and PA inhibitor-1 by human foreskin microvascular endothelial cells
47. Differential distribution and modulation of expression of alpha 1/beta 1 integrin on human endothelial cells
48. Single-step method of RNA isolation by acid guanidinium thiocyanatephenol-chloroform extraction
49. Influence of fibrin structure on the formation and maintenance of capillary-like tubules by human microvascular endothelial cells
50. Hypoxia-induced transcriptional activation and increased mRNA stability of vascular endothelial growth factor in C6 glioma cells
51. Stabilization of vascular endothelial growth factor mRNA by hypoxia and hypoglycemia and coregulation with other ischemia-induced genes
52. Post-transcriptional regulation of vascular endothelial growth factor by hypoxia
53. Vascular endothelial growth factor increases urokinase receptor expression in vascular endothelial cells
54. Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin
55. Definition of two angiogenic pathways by distinct alpha(v) integrins
56. Expression and function of endothelial cell alpha v integrin receptors in wound-induced human angiogenesis in human skin/SCID mice chimeras
57. Identification of a human VPF/VEGF 3' untranslated region mediating hypoxia-induced mRNA stability
58. Receptor-mediated internalization and degradation of urokinase is caused by its specific inhibitor Pai-1
59. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression
60. Accessibility of receptor-bound urokinase to type-1 plasminogen activator inhibitor
61. Hypoxia-inducible factor 1 is a basic helix-loop-helix-PAS heterodimer regulated by cellular O2 tension
62. Separation of oxidant-initiated and redox-regulated steps in the NF-kappa B signal transduction pathway
63. Effect of altered redox states on expression and DNA-binding activity of hypoxia-inducible factor 1
64. Post-transcriptional regulation of erythropoietin mRNA stability by erythropoietin mRNA-binding protein
65. Beta 1 and beta 3 integrins have different roles in the adhesion and migration of vascular smooth muscle cells on extracellular matrix
66. Integrin alpha v beta 3 antagonists promote tumor regression by inducing apoptosis of angiogenic blood vessels